A Research Agenda for Using Machine Translation in Clinical Medicine.
A Research Agenda for Using Machine Translation in Clinical Medicine.
复制标题
在临床医学中使用机器翻译的研究议程。
DOI:
10.1007/s11606-021-07164-y
复制
发表时间:
2022
影响因子:
5.7
通讯作者:
Rodriguez,JorgeA
中科院分区:
文献类型:
--
作者:
Khoong,ElaineC;Rodriguez,JorgeA
P rovision of linguistically appropriate care remains a challenge to achieving health equity. Language barriers impact 25.6 million limited English proficient (LEP) individuals in the USA. LEP patients experience worse healthcare access, quality, and outcomes, partly because systems frequently fail to engage patients in their preferred language. 1 Though interpreters are essential for language-discordant communication, they are underused 2 and may be unavailable in underresourced settings or during times of increased demand, such as during a pandemic. Consequently, clinicians may rely on ad hoc interpreters or defer interpretation. Barriers to interpreter use are compounded by limited language diversity among clinicians. Ultimately, inadequate language access has led to inequities that require urgent attention. Machine translation (MT) presents a tempting solution. MT refers to software that translates (text) or interprets (speech) from one language to another. These tools are available at low cost through websites and mobile apps, making them pragmatic resources for clinicians, particularly when certified (or even ad hoc) translators or interpreters are not available. Though not formally quantified, the use of MT tools in clinical care is likely frequent, reflecting this convenience, and has prompted safety concerns. 3 While the accessibility of MT tools suggests it may solve the challenge of inadequate language resources, the limited real-world healthcare evaluation of MT has prevented broader uptake. While there is preliminary evidence supporting MT accuracy for translating public health information, discharge instructions, and patient portal messages, 4–6 there is scant evidence on MT use for interpretation. 7